Tumor Biology

, Volume 35, Issue 11, pp 11579–11586 | Cite as

Reproductive factors in relation to risk of brain tumors in women: an updated meta-analysis of 27 independent studies

  • Hailiang Zong
  • Hongsheng Xu
  • Zhongqun Geng
  • Chong Ma
  • Xing Ming
  • Ming Shang
  • Kai Li
  • Xiaoguang He
  • Hai Du
  • Jianping Zhao
  • Lei Cao
Research Article

Abstract

Previous studies on the association between reproductive factors and brain tumor risk in women have provided inconclusive findings. Thus, an updated meta-analysis was performed to obtain more precise risk estimates for brain tumor regarding several common reproductive factors. A comprehensive literature search for relevant publications in the PubMed and Embase databases was carried out from their inception up to June 20, 2014. Pooled relative risks (RRs) with corresponding 95 % confidence intervals (CIs) were calculated. There were 27 independent studies with a total of 12,129 cases and 1,433,915 controls included into the present meta-analysis. We found that an elevated risk of brain tumors (RR = 1.17, 95 % CI 1.06–1.29, P = 0.002), particularly glioma (RR = 1.33, 95 % CI 1.15–1.54, P < 0.001), was related to older age at menarche. Interestingly, stratified analysis by type of brain tumors showed that the longer duration of breast feeding was associated with the risk of meningioma negatively but glioma positively (for meningioma: RR = 0.76, 95 % CI 0.64–0.91, P = 0.002; for glioma: RR = 1.70, 95 % CI 1.14–2.55, P = 0.010). No significant association was observed when estimating the roles of other reproductive factors including parity, age at first birth, menopausal status, and age at menopause in brain tumorigenesis. Our study suggests that older age at menarche is a risk factor of brain tumors and glioma in particular. Additionally, more studies are warranted to further elucidate roles and mechanisms of common reproductive factors in the risk of brain tumors.

Keywords

Reproductive factors Meningioma Glioma Meta-analysis 

References

  1. 1.
    Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 2013;15 Suppl 2:ii1–56.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Ostrom QT, Barnholtz-Sloan JS. Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep. 2011;11:329–35.PubMedCrossRefGoogle Scholar
  3. 3.
    Xu C, Yuan L, Tian H, Cao H, Chen S. Association of the MTHFR C677T polymorphism with primary brain tumor risk. Tumour Biol. 2013;34:3457–64.PubMedCrossRefGoogle Scholar
  4. 4.
    Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278–99.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Guo J, Shi L, Li M, Xu J, Yan S, Zhang C, et al. Association of the interleukin-4Ralpha rs1801275 and rs1805015 polymorphisms with glioma risk. Tumour Biol. 2014;35:573–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neuro Oncol. 2010;99:307–14.CrossRefGoogle Scholar
  7. 7.
    Lonn S, Klaeboe L, Hall P, Mathiesen T, Auvinen A, Christensen HC, et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer. 2004;108:450–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Rubinstein AB, Loven D, Geier A, Reichenthal E, Gadoth N. Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg. 1994;81:184–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Khalid MH, Shibata S, Furukawa K, Nadel A, Ammerman MD, Caputy AJ. Role of estrogen receptor-related antigen in initiating the growth of human glioma cells. J Neurosurg. 2004;100:923–30.PubMedCrossRefGoogle Scholar
  10. 10.
    Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, Plunkett RJ. 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett. 2004;213:57–65.PubMedCrossRefGoogle Scholar
  11. 11.
    Anic GM, Madden MH, Nabors LB, Olson JJ, LaRocca RV, Thompson ZJ, et al. Reproductive factors and risk of primary brain tumors in women. J Neuro Oncol. 2014;118:297–304.CrossRefGoogle Scholar
  12. 12.
    Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg. 2013;118:649–56.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Wang SS, Hartge P, Yeager M, Carreon T, Ruder AM, Linet M, et al. Joint associations between genetic variants and reproductive factors in glioma risk among women. Am J Epidemiol. 2011;174:901–8.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE. Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer. 2011;128:944–50.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, Folsom AR, et al. Risk factors for meningioma in postmenopausal women: results from the Iowa Women’s Health Study. Neuro Oncol. 2011;13:1011–9.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Michaud DS, Gallo V, Schlehofer B, Tjonneland A, Olsen A, Overvad K, et al. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev. 2010;19:2562–9.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control. 2010;21:2149–56.PubMedCrossRefGoogle Scholar
  18. 18.
    Felini MJ, Olshan AF, Schroeder JC, Carozza SE, Miike R, Rice T, et al. Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control. 2009;20:87–96.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Wigertz A, Lonn S, Hall P, Auvinen A, Christensen HC, Johansen C, et al. Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev. 2008;17:2663–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Benson VS, Pirie K, Green J, Casabonne D, Beral V. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer. 2008;99:185–90.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Silvera SA, Miller AB, Rohan TE. Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer. 2006;118:1321–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F. Association of meningioma with reproductive factors. Int J Cancer. 2006;119:1152–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Custer B, Longstreth Jr WT, Phillips LE, Koepsell TD, Van Belle G. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer. 2006;6:152.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, et al. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer. 2005;114:797–805.PubMedCrossRefGoogle Scholar
  25. 25.
    Huang K, Whelan EA, Ruder AM, Ward EM, Deddens JA, Davis-King KE, et al. Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev. 2004;13:1583–8.PubMedGoogle Scholar
  26. 26.
    Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer. 1999;82:155–60.PubMedCrossRefGoogle Scholar
  27. 27.
    Lambe M, Coogan P, Baron J. Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer. 1997;72:389–93.PubMedCrossRefGoogle Scholar
  28. 28.
    Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, Giles GG, et al. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer. 1997;71:203–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Preston-Martin S, Monroe K, Lee PJ, Bernstein L, Kelsey J, Henderson S, et al. Spinal meningiomas in women in Los Angeles County: investigation of an etiological hypothesis. Cancer Epidemiol Biomarkers Prev. 1995;4:333–9.PubMedGoogle Scholar
  30. 30.
    Hochberg F, Toniolo P, Cole P, Salcman M. Nonoccupational risk indicators of glioblastoma in adults. J Neuro Oncol. 1990;8:55–60.CrossRefGoogle Scholar
  31. 31.
    Qi ZY, Shao C, Huang YL, Hui GZ, Zhou YX, Wang Z. Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS One. 2013;8:e83261.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Qi ZY, Shao C, Zhang X, Hui GZ, Wang Z. Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies. PLoS One. 2013;8:e68695.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.PubMedCrossRefGoogle Scholar
  34. 34.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  36. 36.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  37. 37.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 470–461.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Saraf S, McCarthy BJ, Villano JL. Update on meningiomas. Oncologist. 2011;16:1604–13.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg. 1997;86:113–20.PubMedCrossRefGoogle Scholar
  41. 41.
    Wahab M, Al-Azzawi F. Meningioma and hormonal influences. Climacteric. 2003;6:285–92.PubMedCrossRefGoogle Scholar
  42. 42.
    Jay JR, MacLaughlin DT, Riley KR, Martuza RL. Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg. 1985;62:757–62.PubMedCrossRefGoogle Scholar
  43. 43.
    Zava DT, Markwalder TM, Markwalder RV. Biological expression of steroid hormone receptors in primary meningioma cells in monolayer culture. Clin Neuropharmacol. 1984;7:382–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93–108.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Hailiang Zong
    • 1
  • Hongsheng Xu
    • 1
  • Zhongqun Geng
    • 2
  • Chong Ma
    • 1
  • Xing Ming
    • 1
  • Ming Shang
    • 1
  • Kai Li
    • 1
  • Xiaoguang He
    • 1
  • Hai Du
    • 1
  • Jianping Zhao
    • 1
  • Lei Cao
    • 1
  1. 1.Department of Neurosurgery, Central Hospital of XuzhouAffiliated Hospital of Southeast UniversityXuzhouChina
  2. 2.Department of Gynecology and ObstetricsThe Xuzhou Maternity and Children’s Health Care HospitalXuzhouChina

Personalised recommendations